Day | Untreated control | Lotilaner | Comparison | |||
---|---|---|---|---|---|---|
Mean | Range | Mean | Range | Efficacy (%) | ||
Study 1 | ||||||
4 | 22.2 (22.4) | 18–29 | 0.2 (0.3) | 0–1 | 99.1 (98.7) | t (14) = 24.07, P < 0.0001 |
9 | 37.6 (39.1) | 23–52 | 0.2 (0.3) | 0–2 | 99.5 (99.2) | t (14) = 20.16, P < 0.0001 |
16 | 13.3 (14.3) | 5–19 | 0.0 (0.0) | 0–0 | 100 (100) | t (14) = 18.54, P < 0.0001 |
23 | 25.1 (32.5) | 4–87 | 0.0 (0.0) | 0–0 | 100 (100) | t (14) = 11.26, P < 0.0001 |
30 | 23.4 (25.1) | 12–41 | 0.0 (0.0) | 0–0 | 100 (100) | t (14) = 21.71, P < 0.0001 |
Study 2 | ||||||
34 | 23.7 (24.5) | 15–36 | 0.0 (0.0) | 0–0 | 100 (100) | t (10) = 28.45, P < 0.0001 |